ANI Pharmaceuticals to Present at Upcoming Investor Conferences

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team, will present at the following investor conferences:

Raymond James & Associates’ 47th Annual Institutional Investors Conference on Tuesday, March 3, 2026, at 7:30am ET

Leerink Partners Global Healthcare Conference on Tuesday, March 10, 2026, at 3:00pm ET

Barclays 28th Annual Global Healthcare Conference on Wednesday, March 11, 2026, at 3:00pm ET

The live and archived webcasts will be accessible from the Company’s website at www.anipharmaceuticals.com , under the Investors section under Events and Presentations. The replays of the webcasts will be accessible for 90 days.

About ANI ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit www.anipharmaceuticals.com .

Investor Relations: Courtney Mogerley, Argot Partners T: 646-368-8014 E: [email protected]